Solvonis Therapeutics Financial Overview
Solvonis Therapeutics's market cap is currently £17.02M. The company's EPS TTM is p0; its P/E ratio is ―; Solvonis Therapeutics is scheduled to report earnings on September 30, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
